Evidence map›Paper›PMID 32560350›Full record

ArticleInternational journal of molecular sciences2020

Proteomic Screening for Prediction and Design of Antimicrobial Peptides with AmpGram.

Michał Burdukiewicz, Katarzyna Sidorczuk, Dominik Rafacz, Filip Pietluch, Jarosław Chilimoniuk, Stefan Rödiger, Przemysław Gagat

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Mining the UniProtKB/Swiss-Prot database for antimicrobial peptides.Protein science : a publication of the Protein Society · 2025
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Michał BurdukiewiczFaculty of Mathematics and Information Science, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0001-8926-582X
Katarzyna SidorczukDepartment of Bioinformatics and Genomics, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland.
Dominik RafaczFaculty of Mathematics and Information Science, Warsaw University of Technology, 00-662 Warsaw, Poland.
Filip PietluchDepartment of Bioinformatics and Genomics, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland.
Jarosław ChilimoniukDepartment of Bioinformatics and Genomics, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland.ORCID 0000-0001-5467-018X
Stefan RödigerFaculty of Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, 01968 Senftenberg, Germany.
Przemysław GagatDepartment of Bioinformatics and Genomics, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland.ORCID 0000-0001-9077-439X
University of Wrocław · PLWarsaw University of Technology · PLBrandenburg University of Technology Cottbus-Senftenberg · DE

Funding

Narodowe Centrum Nauki 2017/26/D/NZ8/00444Narodowe Centrum Nauki 2018/31/N/NZ2/01338Warsaw University of Technology 504/04240/1120
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are molecules widespread in all branches of the tree of life that participate in host defense and/or microbial competition. Due to their positive charge, hydrophobicity and amphipathicity, they preferentially disrupt negatively charged bacterial membranes. AMPs are considered an important alternative to traditional antibiotics, especially at the time when multidrug-resistant bacteria being on the rise. Therefore, to reduce the costs of experimental research, robust computational tools for AMP prediction and identification of the best AMP candidates are essential. AmpGram is our novel tool for AMP prediction; it outperforms top-ranking AMP classifiers, including AMPScanner, CAMPR3R and iAMPpred. It is the first AMP prediction tool created for longer AMPs and for high-throughput proteomic screening. AmpGram prediction reliability was confirmed on the example of lactoferrin and thrombin. The former is a well known antimicrobial protein and the latter a cryptic one. Both proteins produce (after protease treatment) functional AMPs that have been experimentally validated at molecular level. The lactoferrin and thrombin AMPs were located in the antimicrobial regions clearly detected by AmpGram. Moreover, AmpGram also provides a list of shot 10 amino acid fragments in the antimicrobial regions, along with their probability predictions; these can be used for further studies and the rational design of new AMPs. AmpGram is available as a web-server, and an easy-to-use R package for proteomic analysis at CRAN repository.

Indexed as

Drug DesignProteomicsSoftwareAntimicrobial Cationic PeptidesArea Under CurveDatabases, FactualDrug DiscoveryMicrobial Sensitivity TestsSensitivity and SpecificityWeb BrowserAntimicrobial Cationic PeptidesAMPantimicrobial peptideshost defense peptidesmultidrug-resistant bacteriapredictionproteomic screeningrandom forest

Identifiers

PMID32560350
PMCPMC7352166
OpenAlexW3036144909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.